Pfizer in Talks to Acquire Seagen in Deal Likely Valued at More Than $30 B

 Pfizer Inc. PFE -1.30%

decrease; red down pointing triangle is in talks to acquire biotech Seagen Inc., SGEN -0.51%decrease; red down pointing triangle according to people familiar with the matter, the latest potential deal for a big drug company aimed at adding a promising class of targeted cancer therapies.

The talks are at an early stage and there is no guarantee there will be a deal, the people said. A number of hurdles would need to be overcome, including the potential for a stringent antitrust review of any proposal. If there is a deal, it would be big: Seagen has a market value of some $30 billion and would be expected to command a premium over that.

https://www.wsj.com/articles/pfizer-in-early-stage-talks-to-acquire-seagen-3f53309e